Latest Sykes Enterprises Inc (SYKE) Headlines 30.0%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Sykes Enterprises Inc (SYKE) Headlines

30.0% Return Seen to Date on SmarTrend SYKES Enterprises Call (SYKE)
Comtex SmarTrend(R) - Wed Mar 12, 9:20AM CDT
SmarTrend identified an Uptrend for SYKES Enterprises (NASDAQ:SYKE) on May 7th, 2013 at $15.81. In approximately 10 months, SYKES Enterprises has returned 29.98% as of today's recent price of $20.55.

SYKES Enterprises Shares Up 26.9% Since SmarTrend's Buy Recommendation (SYKE)
Comtex SmarTrend(R) - Tue Mar 04, 5:19PM CST
SmarTrend identified an Uptrend for SYKES Enterprises (NASDAQ:SYKE) on May 7th, 2013 at $15.81. In approximately 10 months, SYKES Enterprises has returned 26.88% as of today's recent price of $20.06.

Sykes Enterprises, Incorporated's Chief Financial Officer (CFO) Mike Kipphut Announces Retirement After a Decade and a Half With the Company
GlobeNewswire - Thu Feb 27, 3:00PM CST
Sykes Enterprises, Incorporated ("SYKES" or the "Company") (Nasdaq:SYKE), a global leader in providing comprehensive outsourced customer contact management solutions and services in the business process outsourcing (BPO) arena, announced today that its current Executive Vice President and Chief Financial Officer Mike Kipphut, who has been with the Company since 2000, will be retiring April 15, 2014.

Sykes Enterprises, Incorporated to Present at the Baird 2014 Business Solutions Conference
GlobeNewswire - Thu Feb 20, 12:42PM CST
Sykes Enterprises, Incorporated (Nasdaq:SYKE) ("SYKES" or the "Company"), a global leader in providing outsourced customer contact management solutions and services in the business process outsourcing (BPO) arena, will present at the Baird 2014 Business Solutions Conference in New York City, New York. SYKES' management will provide an overview of the Company, its strategies, and respond to questions.

Sykes Enterprises, Incorporated Reports Fourth-Quarter and Full-Year 2013 Financial Results
GlobeNewswire - Tue Feb 18, 3:00PM CST
--Fourth Quarter 2013 Revenue Tops Business Outlook Range on Better Demand

Uptrend Call Working As SYKES Enterprises Stock Rises 30.1% (SYKE)
Comtex SmarTrend(R) - Tue Feb 18, 9:42AM CST
SmarTrend identified an Uptrend for SYKES Enterprises (NASDAQ:SYKE) on May 7th, 2013 at $15.81. In approximately 10 months, SYKES Enterprises has returned 30.11% as of today's recent price of $20.57.

Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman
Marketwire - Thu Jan 30, 6:38AM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, is pleased to announce that its Board of Directors has elected Dr. Calvin R. Stiller as Chairman of the Board. Dr. Stiller has been a member of the Board since July 2011 and served as Lead Director and Chair of the Governance and Nominating Committee.

Sykes Enterprises, Incorporated to Webcast Fourth-Quarter and Full-Year 2013 Financial Results
GlobeNewswire - Fri Jan 24, 9:00AM CST
Sykes Enterprises, Incorporated ("SYKES" or the "Company") (Nasdaq:SYKE), a global leader in providing comprehensive outsourced customer contact management solutions and services in the business process outsourcing (BPO) arena, announced today it will release financial results for the fourth-quarter and full-year ended December 31, 2013, on February 18, 2014, after the market close.

SYKES Enterprises Up 32.7% Since SmarTrend Uptrend Call (SYKE)
Comtex SmarTrend(R) - Thu Jan 09, 5:17PM CST
SmarTrend identified an Uptrend for SYKES Enterprises (NASDAQ:SYKE) on May 7th, 2013 at $15.81. In approximately 8 months, SYKES Enterprises has returned 32.70% as of today's recent price of $20.98.

SYKES Enterprises Has Returned 36.1% Since SmarTrend Recommendation (SYKE)
Comtex SmarTrend(R) - Thu Jan 02, 11:09AM CST
SmarTrend identified an Uptrend for SYKES Enterprises (NASDAQ:SYKE) on May 7th, 2013 at $15.81. In approximately 8 months, SYKES Enterprises has returned 36.12% as of today's recent price of $21.52.

SYKES Enterprises Shares Up 31.8% Since SmarTrend's Buy Recommendation (SYKE)
Comtex SmarTrend(R) - Wed Dec 18, 9:46AM CST
SmarTrend identified an Uptrend for SYKES Enterprises (NASDAQ:SYKE) on May 7th, 2013 at $15.81. In approximately 8 months, SYKES Enterprises has returned 31.82% as of today's recent price of $20.84.

USA Technologies (USAT) Catches Eye: Stock Jumps 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 05, 7:11AM CST
USA Technologies (USAT) was a big mover last session, as the company saw its shares rise nearly 7% on the day.

Sykes Enterprises Inc. (SYKE) Stock Research Links

SYKE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

OMI Advances Eco-Friendly Off-Road Vehicle Solutions

Updated Category News Views 194

OMI's Groundbreaking Fusion Drive Hybrid System OMI, a prominent electromechanical company, has exciting news: their innovative "Fusion Drive" hybrid system for off-road vehicles is now in its final demonstration phase. After more than three years of dedicated development, this cutting-edge technology is poised to redefine the off-road vehicle landscape. OMI anticipates a...

Continue Reading
Oak Valley Health Leverages Sectra Cloud for Better Care

Updated Category News Views 9

Strategic Shift to Cloud for Enhanced Security Let me tell you, the healthcare game is changing, and Oak Valley Health is clearly not sitting on its laurels. They've partnered up with Sectra, the medical imaging IT and cybersecurity whiz out of Sweden, to transition to Sectra One Cloud. Now, for those unfamiliar, that's a pretty slick move. It means they've decided all...

Continue Reading
Enhanced Greasing Solutions Transforming Forest Machine Maintenance

Updated Category News Views 159

Introducing PONSSE Greasing System for Efficient Lubrication The PONSSE Greasing System represents a significant advancement in the realm of forest machinery, specifically designed to enhance the functionality of PONSSE harvester heads. This innovative greasing system is an optional accessory tailored for chainsaw lubrication, ensuring that each component operates...

Continue Reading
Transforming $100 into Wealth: The Verisk Analytics Journey

Updated Category News Views 222

Understanding the Growth of Verisk Analytics Verisk Analytics (NASDAQ: VRSK) has consistently demonstrated strong performance in the market, outperforming many of its peers over the past 15 years. With an average annual return of 13.53%, it has shown investors just how powerful compounded returns can be. Today, the company's market capitalization stands impressively at...

Continue Reading
Understanding the Silver Tsunami: Wealth Transfer Insights

Updated Category News Views 231

Understanding the Silver Tsunami: Wealth Transfer Insights The concept of the Silver Tsunami, referring to the massive wealth transfer linked to Baby Boomers, is taking center stage in today's economic discussions. Recent analyses indicate that a significant portion of homeowners born before 1964 is poised to pass down their accumulated wealth, predominantly through home...

Continue Reading